Wegovy vs Ozempic
Ozempic
GLP-1 receptor agonist for diabetes and weight management with established clinical data.
Patients with type 2 diabetes seeking cardiovascular protection and glucose control
VS
Wegovy
Higher-dose semaglutide injection specifically approved for chronic weight management and obesity treatment.
Adults with obesity or overweight seeking significant weight reduction and cardiovascular risk reduction
Short Answer
Wegovy and Ozempic both contain semaglutide but serve different primary purposes: Ozempic treats type 2 diabetes with doses up to 2.0 mg weekly, while Wegovy is FDA-approved for weight loss with doses up to 2.4 mg weekly (and a new 7.2 mg HD formulation approved in 2026). Wegovy demonstrates superior weight loss efficacy, while Ozempic is more established for diabetes management.
Our Verdict
Both Wegovy and Ozempic are legitimate, FDA-approved semaglutide medications with proven efficacy, but they target different primary conditions. Ozempic remains the established choice for type 2 diabetes management, while Wegovy is purpose-built for weight loss with superior documented results in that domain. The 2026 approval of Wegovy HD's 7.2 mg dose expands options for patients requiring more aggressive weight management.
Ozempic7.5
7.5Wegovy
Choose Ozempic if
Patients with type 2 diabetes seeking cardiovascular protection and glucose control
Track this comparison
Get notified when prices change, new specs ship, or our verdict updates.
Triggers: price change new spec verdict update
No spam. Stop anytime.
Key Differences at a Glance
🔹
Primary FDA-Approved Use: Type 2 Diabetes & Cardiovascular Prevention vs Weight Loss & Cardiovascular Prevention
🔹
Maximum Approved Dose: Wegovy wins (7.2 mg weekly (HD formulation as of 2026) vs 2.0 mg weekly)
⚖️
Weight Loss Efficacy: Wegovy wins (Superior (primary indication) vs Moderate (off-label use))
Key Facts & Figures
| Metric | Ozempic | Wegovy | Diff |
|---|---|---|---|
| Monthly Cost (without insurance)(USD) | ~$900 | ~$1,300 | -31% |
| Maximum Weekly Dose(mg) | 2.0 mg | 7.2 mg (HD formulation) | -72% |
| FDA Approval Year(year) | 2017 |
Key Differences
Ozempic
Attribute
Wegovy
Type 2 Diabetes & Cardiovascular Prevention
Primary FDA-Approved Use
Weight Loss & Cardiovascular Prevention
2.0 mg weekly
Maximum Approved Dose
7.2 mg weekly (HD formulation as of 2026)🏆
Moderate (off-label use)
Weight Loss Efficacy
Superior (primary indication)🏆
Related Comparisons
W
O
Wegovy vs Ozempic
health
O
W
Ozempic vs Wegovy
health
O
M
Ozempic vs Mounjaro
health
i
S
iPhone 17 vs Samsung Galaxy S26
technology
P
X
PS5 vs Xbox Series X
technology
M
W
Mac vs Windows
technology
A
S
Apple vs Samsung
brands
A
i
Android vs iOS
technology
N
A
Nike vs Adidas
brands
N
A
NVIDIA vs AMD
technology
C
P
Coca-Cola vs Pepsi
brands
S
A
Spotify vs Apple Music
technology
Related Articles
technology
Best Streaming Services in 2026: Top Picks for Every Budget & Interest
Navigating the crowded streaming landscape in 2026 can be overwhelming. We've tested and ranked the best streaming services that offer the most value, from Netflix's massive library to budget-friendly options like Tubi, helping you cut cable and find your perfect entertainment solution.
technology
Best Live TV Streaming Services & Plans for Spring 2026: Complete Buyer's Guide
Tired of overpaying for cable? Discover the best live TV streaming services and plans for Spring 2026, including YouTube TV's new genre-based packages starting at $55/month. Our comprehensive guide breaks down pricing, channels, and features to help you cut the cord.
Last updated: March 27, 2026AI generated
